These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure. Nzerue CM; Thomas J; Volcy J; Edeki T Int J Artif Organs; 2003 Jan; 26(1):86-9. PubMed ID: 12602474 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of repaglinide-induced hypoglycemia with octreotide. Fasano CJ; Rowden AK Am J Emerg Med; 2009 Jul; 27(6):756.e3-4. PubMed ID: 19751648 [No Abstract] [Full Text] [Related]
5. Octreotide therapy for nateglinide-induced hypoglycemia. Sherk DK; Bryant SM Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765 [No Abstract] [Full Text] [Related]
6. Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect. Kelesidis T; Canseco E Am J Med; 2010 Feb; 123(2):e5-6. PubMed ID: 20103009 [No Abstract] [Full Text] [Related]
8. Octreotide for sulfonylurea-induced hypoglycemia following overdose. Carr R; Zed PJ Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia. Graudins A; Linden CH; Ferm RP Am J Emerg Med; 1997 Jan; 15(1):95-6. PubMed ID: 9002583 [No Abstract] [Full Text] [Related]
10. Delayed hypoglycemia after ingestion of a single glipizide tablet. Robertson WO Ann Emerg Med; 1999 Jan; 33(1):130-1. PubMed ID: 9867907 [No Abstract] [Full Text] [Related]
11. Delayed hypoglycemia after ingestion of a single glipizide tablet. Mullins ME; Warden CR; Horowitz BZ Ann Emerg Med; 1999 Jan; 33(1):129-30. PubMed ID: 9867906 [No Abstract] [Full Text] [Related]
12. Hypoglycemia. Making a case for glucose gels and tablets. Hutchinson C; Peppard C Nursing; 1998 Aug; 28(8):68-9. PubMed ID: 9739261 [No Abstract] [Full Text] [Related]
13. Sulfonylurea Poisoning in a Healthy Toddler. Kumar S; Choudhary A; Ali M; Gupta V; Muralidharan J; Singhi SC Indian J Pediatr; 2017 Feb; 84(2):147-149. PubMed ID: 27796819 [TBL] [Abstract][Full Text] [Related]
14. Octreotide's role in the management of sulfonylurea-induced hypoglycemia. Dougherty PP; Klein-Schwartz W J Med Toxicol; 2010 Jun; 6(2):199-206. PubMed ID: 20352540 [TBL] [Abstract][Full Text] [Related]
15. Case files of the Medical Toxicology Fellowship Training Program at the Children's Hospital of Philadelphia: a pediatric exploratory sulfonylurea ingestion. Calello DP; Kelly A; Osterhoudt KC J Med Toxicol; 2006 Mar; 2(1):19-24. PubMed ID: 18072108 [No Abstract] [Full Text] [Related]
17. Delayed hypoglycemia in a child after ingestion of a single glipizide tablet. Szlatenyi CS; Capes KF; Wang RY Ann Emerg Med; 1998 Jun; 31(6):773-6. PubMed ID: 9624321 [TBL] [Abstract][Full Text] [Related]
18. Prolonged hypoglycaemia secondary to extended-release form glipizide. Cakir M; Akin M; Karayalcin U Diabetes Obes Metab; 2004 Jul; 6(4):310-1. PubMed ID: 15171757 [No Abstract] [Full Text] [Related]
19. Sulfonylurea-induced hypoglycaemia: use of octreotide. Hanchard B; Boulouffe C; Vanpee D Acta Clin Belg; 2009; 64(1):56-8. PubMed ID: 19317242 [TBL] [Abstract][Full Text] [Related]
20. Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia. Barkin JA; Block HM; Mendez PE Pancreas; 2013 May; 42(4):722-3. PubMed ID: 23591434 [No Abstract] [Full Text] [Related] [Next] [New Search]